Skip to main content
Erschienen in: Rheumatology International 3/2015

01.03.2015 | Short Communication - Observational Research

Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan

verfasst von: Nobuyuki Ono, Hiroaki Niiro, Akira Ueda, Takuya Sawabe, Hiroaki Nishizaka, Isao Furugo, Seiji Yoshizawa, Shigeru Yoshizawa, Hiroshi Tsukamoto, Chikako Kiyohara, Yoshifumi Tada, Takahiko Horiuchi

Erschienen in: Rheumatology International | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

We studied the clinico-pathological differences among PR3-ANCA-positive granulomatosis with polyangiitis (PR3-GPA), MPO-ANCA-positive GPA (MPO-GPA) and microscopic polyangiitis (MPA). ANCA-associated vasculitis (AAV) was classified using the European Medicines Agency classification. We retrospectively analyzed 38 patients with GPA and 41 with MPA treated in eight hospitals in Japan. Of the patients with GPA, 17 were positive for MPO-ANCA, and 15 for PR3-ANCA. All patients with MPA were MPO-ANCA positive. The mean ages of those with MPO-GPA were 69.6 years old, 10 years older than those with PR3-GPA. The majority (82 %) of patients with MPO-GPA were woman, a significantly greater proportion than for PR3-GPA. We also found that ear, nose and throat (ENT), nervous system involvement were significantly more common in MPO-GPA, but renal function was less impaired than those with MPA. Both PR3-GPA and MPO-GPA relapsed more frequently than MPA, but overall survival was significantly better (P < 0.01 and P < 0.05, respectively). Univariate analysis identified the following factors as predictors of a poor prognosis: MPA (P < 0.01), pulmonary UIP pattern (P < 0.005) Cr ≥ 1.7 mg/dl (P < 0.01) and absence of ENT involvement (P < 0.05), which were characteristics of MPA. In our cohort, MPO-GPA was most likely to affect older women and was associated with otitis media, nervous system involvement, mild renal impairment and more favorable outcome. It is clinically useful to differentiate MPO-GPA from MPA and PR3-GPA in patients with AAV.
Literatur
1.
Zurück zum Zitat Kallenberg CG, Heeringa P, Stegeman CA (2006) Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheum 2:661–670CrossRef Kallenberg CG, Heeringa P, Stegeman CA (2006) Mechanisms of disease: pathogenesis and treatment of ANCA-associated vasculitides. Nat Clin Pract Rheum 2:661–670CrossRef
2.
Zurück zum Zitat Liu LJ, Chen M, Wang HY et al (2008) Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford) 47:708–712CrossRef Liu LJ, Chen M, Wang HY et al (2008) Evaluation of a new algorithm in classification of systemic vasculitis. Rheumatology (Oxford) 47:708–712CrossRef
3.
Zurück zum Zitat Lionaki S, Blyth ER, Falk RJ et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 64:3452–3462CrossRefPubMedCentralPubMed Lionaki S, Blyth ER, Falk RJ et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 64:3452–3462CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Watts R, Lane S, Scott D et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227CrossRefPubMedCentralPubMed Watts R, Lane S, Scott D et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227CrossRefPubMedCentralPubMed
6.
Zurück zum Zitat Raghu G, Collard HR, Schünemann HJ et al (2011) ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRefPubMed Raghu G, Collard HR, Schünemann HJ et al (2011) ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRefPubMed
7.
Zurück zum Zitat Guillevin L, Pagnoux C, Le Toumelin P et al (2011) French Vasculitis Study Group (FVSG). The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90:19–27CrossRef Guillevin L, Pagnoux C, Le Toumelin P et al (2011) French Vasculitis Study Group (FVSG). The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90:19–27CrossRef
8.
Zurück zum Zitat Lane SE, Watts RA, Scott DG et al (2005) Primary systemic vasculitis: clinical features and mortality. QJM 98:97–111CrossRefPubMed Lane SE, Watts RA, Scott DG et al (2005) Primary systemic vasculitis: clinical features and mortality. QJM 98:97–111CrossRefPubMed
9.
Zurück zum Zitat Mohammad AJ, Jacobsson LT, Segelmark M et al (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337CrossRef Mohammad AJ, Jacobsson LT, Segelmark M et al (2007) Prevalence of Wegener’s granulomatosis, microscopic polyangiitis, polyarteritis nodosa and Churg-Strauss syndrome within a defined population in southern Sweden. Rheumatology (Oxford) 46:1329–1337CrossRef
10.
Zurück zum Zitat Mahr A, Girard T, Guillevin L et al (2001) Analysis of factors predictive of survival based on 49 patients with systemic Wegener’s granulomatosis and prospective follow-up. Rheumatology (Oxford) 40:492–498CrossRef Mahr A, Girard T, Guillevin L et al (2001) Analysis of factors predictive of survival based on 49 patients with systemic Wegener’s granulomatosis and prospective follow-up. Rheumatology (Oxford) 40:492–498CrossRef
11.
Zurück zum Zitat Kim HW, Kim JW, Song YW et al (2013) The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener’s): a retrospective study of 45 patients in Korea. Mod Rheumatol 23:864–871CrossRefPubMed Kim HW, Kim JW, Song YW et al (2013) The clinicopathologic characteristics of granulomatosis with polyangiitis (Wegener’s): a retrospective study of 45 patients in Korea. Mod Rheumatol 23:864–871CrossRefPubMed
12.
Zurück zum Zitat Guillevin L, Durand-Gasselin B, Jarrousse B et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefPubMed Guillevin L, Durand-Gasselin B, Jarrousse B et al (1999) Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 42:421–430CrossRefPubMed
14.
Zurück zum Zitat Yamagata K, Usui J, Matsuo S et al (2012) ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol 16:580–588CrossRefPubMed Yamagata K, Usui J, Matsuo S et al (2012) ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes. Clin Exp Nephrol 16:580–588CrossRefPubMed
15.
Zurück zum Zitat Ono N, Yoshihiro K, Ueda A et al (2013) Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature. Mod Rheumatol 23:554–563CrossRefPubMed Ono N, Yoshihiro K, Ueda A et al (2013) Four cases of MPO-ANCA-positive vasculitis with otitis media, and review of the literature. Mod Rheumatol 23:554–563CrossRefPubMed
16.
Zurück zum Zitat Furuta S, Chaudhry AN, Jayne D et al (2014) Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol 4:325–333CrossRef Furuta S, Chaudhry AN, Jayne D et al (2014) Comparison of phenotype and outcome in microscopic polyangiitis between Europe and Japan. J Rheumatol 4:325–333CrossRef
17.
Zurück zum Zitat Yokoseki A, Saji E, Kawachi I et al (2014) Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain 137:520–536CrossRefPubMed Yokoseki A, Saji E, Kawachi I et al (2014) Hypertrophic pachymeningitis: significance of myeloperoxidase anti-neutrophil cytoplasmic antibody. Brain 137:520–536CrossRefPubMed
18.
Zurück zum Zitat Arulkumaran N, Periselneris N, Salama AD (2011) Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 50:2035–2043CrossRef Arulkumaran N, Periselneris N, Salama AD (2011) Interstitial lung disease and ANCA-associated vasculitis: a retrospective observational cohort study. Rheumatology (Oxford) 50:2035–2043CrossRef
Metadaten
Titel
Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: a retrospective multi-center study in Japan
verfasst von
Nobuyuki Ono
Hiroaki Niiro
Akira Ueda
Takuya Sawabe
Hiroaki Nishizaka
Isao Furugo
Seiji Yoshizawa
Shigeru Yoshizawa
Hiroshi Tsukamoto
Chikako Kiyohara
Yoshifumi Tada
Takahiko Horiuchi
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Rheumatology International / Ausgabe 3/2015
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-014-3106-z

Weitere Artikel der Ausgabe 3/2015

Rheumatology International 3/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.